[go: up one dir, main page]

DK1159968T3 - Attenuerede stammer af Dengue-virus og deres anvendelse i en vaccinesammensætning - Google Patents

Attenuerede stammer af Dengue-virus og deres anvendelse i en vaccinesammensætning

Info

Publication number
DK1159968T3
DK1159968T3 DK00420113T DK00420113T DK1159968T3 DK 1159968 T3 DK1159968 T3 DK 1159968T3 DK 00420113 T DK00420113 T DK 00420113T DK 00420113 T DK00420113 T DK 00420113T DK 1159968 T3 DK1159968 T3 DK 1159968T3
Authority
DK
Denmark
Prior art keywords
dengue virus
attenuated strains
vaccine composition
serotype
attenuated
Prior art date
Application number
DK00420113T
Other languages
English (en)
Inventor
Nath Bhamarapravat
Sutee Yoksan
Original Assignee
Univ Mahidol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mahidol filed Critical Univ Mahidol
Application granted granted Critical
Publication of DK1159968T3 publication Critical patent/DK1159968T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00420113T 2000-05-30 2000-05-30 Attenuerede stammer af Dengue-virus og deres anvendelse i en vaccinesammensætning DK1159968T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00420113A EP1159968B1 (fr) 2000-05-30 2000-05-30 Souches atténuées du virus de la Dengue et leur utilisation dans une composition vaccinale

Publications (1)

Publication Number Publication Date
DK1159968T3 true DK1159968T3 (da) 2009-02-23

Family

ID=8174060

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00420113T DK1159968T3 (da) 2000-05-30 2000-05-30 Attenuerede stammer af Dengue-virus og deres anvendelse i en vaccinesammensætning

Country Status (7)

Country Link
EP (1) EP1159968B1 (da)
AT (1) ATE412738T1 (da)
CY (1) CY1108666T1 (da)
DE (1) DE60040652D1 (da)
DK (1) DK1159968T3 (da)
ES (1) ES2315221T3 (da)
PT (1) PT1159968E (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10655110B2 (en) 2015-11-27 2020-05-19 Km Biologics Co., Ltd. Multivalent dengue vaccine composition comprising a mixture of attenuated dengue viruses from different serotypes

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006134433A1 (en) * 2005-06-17 2006-12-21 Sanofi Pasteur Dengue serotype 1 attenuated strain
JP5075120B2 (ja) 2005-06-17 2012-11-14 サノフィ・パスツール デング熱セロタイプ２の弱毒化株
US7968102B2 (en) 2006-01-13 2011-06-28 Sanofi Pasteur S.A. Dengue chimeric viruses
AR061197A1 (es) * 2006-06-07 2008-08-13 Sanofi Pasteur Cepas del virus 3 del dengue vivas atenuadas
FR2903605A1 (fr) 2006-07-12 2008-01-18 Sanofi Pasteur Sa Methode d'immunisation contre les quatres serotypes de la dengue
FR2906724B1 (fr) 2006-10-04 2009-03-20 Sanofi Pasteur Sa Methode d'immunisation contre les 4 serotypes de la dengue.
FR2909286B1 (fr) * 2006-12-01 2012-06-08 Sanofi Pasteur Methode d'immunisation contre les 4 serotypes de la dengue
CN105944095B (zh) 2008-03-05 2021-04-02 赛诺菲巴斯德有限公司 一种使含佐剂的疫苗组合物稳定的方法
EP2143440A1 (fr) 2008-07-09 2010-01-13 Sanofi Pasteur Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
EP2353609A1 (en) 2010-02-04 2011-08-10 Sanofi Pasteur Immunization compositions and methods
BR112015001313A2 (pt) 2012-07-24 2017-08-01 Sanofi Pasteur composições de vacina
MY197723A (en) 2012-07-24 2023-07-10 Sanofi Pasteur Vaccine compositions for the prevention of dengue virus infection
WO2014083194A1 (en) 2012-11-30 2014-06-05 Sanofi Pasteur Methods for inducing antibodies
PE20211814A1 (es) * 2013-03-15 2021-09-14 Takeda Vaccines Inc Composiciones y metodos de construcciones quimericas del virus del dengue en vacunas
BE1024160B9 (fr) 2015-12-22 2017-12-06 Glaxosmithkline Biologicals Sa Formulation immunogène
SG11202002933TA (en) 2017-10-05 2020-04-29 Sanofi Pasteur Compositions for booster vaccination against dengu
US11426461B2 (en) 2018-09-05 2022-08-30 Takeda Vaccines, Inc. Methods for preventing dengue and hepatitis A

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6093296A (en) * 1995-06-07 1996-12-30 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Infectious dengue 2 virus pdk-53 as quadravalent vaccine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10655110B2 (en) 2015-11-27 2020-05-19 Km Biologics Co., Ltd. Multivalent dengue vaccine composition comprising a mixture of attenuated dengue viruses from different serotypes

Also Published As

Publication number Publication date
ATE412738T1 (de) 2008-11-15
PT1159968E (pt) 2008-11-20
ES2315221T3 (es) 2009-04-01
EP1159968B1 (fr) 2008-10-29
EP1159968A1 (fr) 2001-12-05
CY1108666T1 (el) 2014-04-09
DE60040652D1 (de) 2008-12-11

Similar Documents

Publication Publication Date Title
CY1108666T1 (el) Εξασθενημενα στελεχη του δαγγειου πυρετου και η χρηση τους σε μια συνθεση εμβολιου
EA200300023A1 (ru) 3'-ПРОЛЕКАРСТВА 2'-ДЕЗОКСИ-β-L-НУКЛЕОЗИДОВ
BRPI0309631A8 (pt) vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3 e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4
EA200000840A1 (ru) Антивирусные производные пиримидина
ECSP045300A (es) Antígenos virales
BRPI9911870B8 (pt) vacina de parvovírus e circovírus de suíno
IS8448A (is) Lifrarbólgu C-veirutálmar
NO20026044L (no) Behandling av humant papillomavirus
GT200000103A (es) Trifluorbutenos nematocidas.
DE60114865D1 (de) Heterologe herstellung von polyketiden
ATE269312T1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren
LU91758I2 (fr) Denosumab et ses dérivés pharmaceutiquement acceptables (PROLIA®)
NO20040845L (no) Substituerte indeno[1,2-c]isokinolinderivater og deres anvendelse
NO985066L (no) Terapeutisk behandling for VEGF-relaterte sykdommer
ATE265535T1 (de) Pharmazeutische zusammensetzung gegen durch papillomaviren verursachte tumoren und infektionen
WO2002072803A3 (en) Subgenomic replicons of the flavivirus dengue
DK1204659T3 (da) Serotonerge benzofuraner
ES2154879T3 (es) Compuestos antiviricos.
DE69703672D1 (de) Antivirusverbindungen
DE69705582D1 (de) Antivirusverbindungen
ES2155239T3 (es) Compuestos antiviricos.
ATE109139T1 (de) Mittel zum schutz von pflanzen gegen krankheiten.
NO20015202D0 (no) <beta>-hydroksyalkylamider, fremgangsmåte for deres fremstilling og deres anvendelse
ATE322541T1 (de) Pestivirus mutanten und dessen enthaltende impfstoffe
ATE203008T1 (de) Antivirusverbindungen